Primary Myelofibrosis Patient Cohort from Mayo Clinic, 1000 Cases

One thousand patient records from the Mayo Clinic experience with primary myelofibrosis, a rare bone marrow cancer. The data was discussed by Dr. Ayalew Tefferi in a January 2012 article in Mayo Clinic Proceedings. It provides context for the design and interpretation of clinical trials for this condition.

Use Cases

• Analyze clinical characteristics of primary myelofibrosis based on the described patient cohort.
• Benchmark treatment outcomes or survival statistics based on the Mayo Clinic experience.
• Design or interpret clinical trials for myelofibrosis based on the provided patient context.
• Study disease progression patterns in primary myelofibrosis based on the longitudinal patient data.

Strengths

• Data originates from a single, high-profile medical institution (Mayo Clinic).
• Focuses on a specific, rare disease (primary myelofibrosis) with a substantial cohort size of 1000 patients.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Last update date is unknown; freshness unverified.

Provenance

Source

Mayo Clinic Proceedings article by Dr. Ayalew Tefferi.

Collection Method

Clinical patient cohort from the Mayo Clinic experience.

Geography

Rochester, MN, USA (Mayo Clinic).